CCME Global Limited Receives BSE Listing Approval for 3,22,50,000 Equity Shares Issued on Preferential Basis
CCME Global Limited (formerly Genesis IBRC India Limited) received BSE listing approval on April 29, 2026, for 3,22,50,000 equity shares of INR 10 each issued at par on preferential basis to promoters and non-promoters. The shares carry distinctive numbers from 13000001 to 45250000, and the company announced this development on April 30, 2026, under Regulation 30 compliance. BSE has specified various compliance requirements including SEBI regulation adherence and mandated trading approval application within seven working days of listing approval.

*this image is generated using AI for illustrative purposes only.
CCME Global Limited (formerly known as Genesis IBRC India Limited) has received listing approval from BSE Limited for a significant equity share issuance on preferential basis. The company announced this development on April 30, 2026, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Share Issuance Details
The BSE approval covers the listing of substantial equity shares issued to both promoters and non-promoters on a preferential basis.
| Parameter: | Details |
|---|---|
| Number of Shares: | 3,22,50,000 equity shares |
| Face Value: | INR 10 each |
| Issue Price: | At par (INR 10) |
| Distinctive Numbers: | 13000001 to 45250000 |
| Issue Basis: | Preferential issue |
| Recipients: | Promoters and Non-Promoters |
BSE Approval and Compliance Requirements
BSE Limited granted the listing approval on April 29, 2026, through its letter reference LOD/PREF/DA/FIP/150/2026-27. The exchange has specified several compliance requirements that the company must fulfill.
Key compliance obligations include:
- Adherence to Regulation 167 of SEBI (ICDR) Regulations
- Filing shareholding pattern in XBRL mode if changes exceed two percent of total paid-up share capital
- Compliance with Regulation 31(1)(c) of SEBI LODR Regulations, 2015
Trading Approval Requirements
BSE has outlined specific conditions that must be met before trading approval is granted for the newly issued shares:
- Listing approval from National Stock Exchange of India Ltd. (if applicable)
- Confirmation letters from NSDL/CDSL regarding crediting shares to beneficiary accounts
- Confirmation of admitting the capital to the depository system
- Lock-in confirmation for pre-preferential holdings (if applicable)
Timeline and Regulatory Compliance
The company must submit an application for trading approval within seven working days from the date of listing approval, as per Schedule XIX of ICDR Regulations and SEBI circular SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023. Non-compliance with this timeline requirement will attract penalties as specified in the regulatory circular.
Company Information
CCME Global Limited operates under CIN L46909AP1992PLC107068 with its registered office located in Eluru, Andhra Pradesh, and corporate office in Mumbai. The announcement was signed by Poonam Chaturvedi, Managing Director (DIN: 05163733), confirming the receipt of BSE's listing approval for the preferential issue.
Historical Stock Returns for CCME Global
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.63% | +18.97% | +13.10% | -29.11% | +453.93% | +1,400.67% |
How will CCME Global utilize the INR 32.25 crore raised through this preferential issue for its business expansion or debt reduction?
What impact will the dilution from 3.22 crore new shares have on existing shareholders' voting rights and earnings per share?
Will CCME Global seek concurrent listing approval from NSE to enhance liquidity and trading volumes for the new shares?


































